Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
RESEARCH TOOLSreports
Holding PTGX?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 4.67M | $ 4.17M | $ 254.95M | $ 60.00M | - |
| Gross Profit | $ 4.67M | $ 4.17M | $ 254.95M | $ 60.00M | - |
| EBIT | $ -33.61M | $ -31.32M | $ 206.31M | $ 23.05M | $ -38.33M |
| EBITDA | $ -32.96M | $ -28.81M | $ 207.13M | $ 23.88M | $ -37.50M |
| Net Income Common Stockholders | $ -33.21M | $ -30.59M | $ 207.34M | $ 27.34M | $ -34.10M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 468.72M | $ 564.04M | $ 322.67M | $ 341.63M | $ 320.73M |
| Total Assets | $ 603.86M | $ 614.63M | $ 629.28M | $ 357.95M | $ 330.02M |
| Total Debt | $ 10.90M | $ 10.97M | $ 462.00K | $ 1.14M | $ 1.80M |
| Net Debt | $ -457.82M | $ -553.07M | $ -322.21M | $ -340.49M | $ -318.92M |
| Total Liabilities | $ 71.94M | $ 73.31M | $ 68.83M | $ 21.27M | $ 27.87M |
| Stockholders Equity | $ 531.91M | $ 541.31M | $ 560.41M | $ 336.68M | $ 302.15M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -28.64M | $ 268.59M | $ -27.67M | $ 16.94M | $ -27.02M |
| Operating Cash Flow | $ -27.86M | $ 268.62M | $ -27.43M | $ 16.96M | $ -26.61M |
| Investing Cash Flow | $ -208.71M | $ -88.12M | $ 6.07M | $ -61.29M | $ -13.56M |
| Financing Cash Flow | $ 12.05M | $ 2.57M | $ 7.20M | $ 527.00K | $ 35.31M |